BIO World Congress on Industrial Biotechnology — Part 2

Earlier this week, I attended the 10th Annual BIO World Congress on Industrial Biotechnology in Montreal. Overall, I found it to be a great show, with over 1,000 attendees from all segments of the renewable fuels and industrial biotech space. The topics presented at the breakout sessions ranged all over the breadth of the field, and included technical talks as well as business and policy talks.

I’ve now written a summary of another of the breakout sessions I attended. This was the second of two panels that discussed the current status of efforts to commercialize cellulosic ethanol. This session, held on Wednesday, June 19, the last day of the conference, featured speakers from Enerkem, Mascoma, DuPont and Abengoa. You can once again find my summary on the Advanced Biofuels USA website.

Earlier this week, I posted a summary of the first cellulosic ethanol panel from the World Congress, that was held on Monday, June 17. That session featured speakers from Clariant, Praj, DSM and Beta Renewables, and you can find that summary on the Advanced Biofuels USA website as well.  My thanks to Joanne Ivancic for giving me the opportunity to contribute these stories to her very useful and informative site. I’d also mention that two previous posts on this blog, from February 21 and February 25, provide additional information on the companies who are commercializing, or are close to commercializing, cellulosic ethanol in the U.S. and elsewhere in the world.

As you’ll see in these two stories, there were a number of common trends in business models and technical approaches that were evident from the different company presentations at these two panels. But overall, it was good to see evidence that this will finally be the year in which cellulosic ethanol is commercially produced in significant volumes.

D. Glass Associates, Inc. is a consulting company specializing in government and regulatory affairs support for renewable fuels and industrial biotechnology. David Glass, Ph.D. is a veteran of over thirty years in the biotechnology industry, with expertise in industrial biotechnology regulatory affairs, U.S. and international renewable fuels regulation, patents, technology licensing, and market and technology assessments. More information on D. Glass Associates’ regulatory affairs consulting capabilities is available at